| ids | sex | population |
|---|---|---|
| ERR188044_chrX | male | YRI |
| ERR188104_chrX | male | YRI |
| ERR188234_chrX | female | YRI |
| ERR188245_chrX | female | GBR |
| ERR188257_chrX | male | GBR |
| ERR188273_chrX | female | YRI |
| ERR188337_chrX | female | GBR |
| ERR188383_chrX | male | GBR |
| ERR188401_chrX | male | GBR |
| ERR188428_chrX | female | GBR |
| ERR188454_chrX | male | YRI |
| ERR204916_chrX | female | YRI |
Differential Expression Analysis of Chromosome X RNA-seq Data
Overview
This analysis evaluates transcriptional variations on Chromosome X (chrX) between male and female individuals to uncover sex-specific dynamics. This study utilizes a cohort of 12 paired-end RNA Sequencing (RNAseq) samples obtained from distinct geographical populations. By adjusting for population structure, this analysis isolates robust sex-linked genetic expression underlying chromosome-wide regulation mechanisms.
Methods
Data Processing
Raw paired-end sequencing reads were processed using a reproducible, custom Nextflow DSL2 pipeline hosted at github.com/DevonAllies/rnaseq-pipeline. The computational workflow was systemically executed using the following steps:
| Step | Tool | Purpose |
|---|---|---|
| FastQC | Assess raw read quality | |
| Adapter trimming | Trim Galore | Remove sequencing adapters |
| Alignment | HISAT2 | Splice-aware alignment to chrX |
| Assembly | StringTie | Per-sample transcript quantification |
| Merging | StringTie merge | Consensus transcriptome across samples |
| Re-estimation | StringTie | Re-quantify against merged Gene Transfer Format (GTF) |
| QC report | MultiQC | Aggregate quality metrics |
The pipeline execution was controlled via the baseline terminal command:
nextflow run rnaseq.nf -profile local --hisat2_prefix indexes/chrX_tranDifferential Expression
Downstream Differential Expression (DE) modeling was performed at the gene level using the Ballgown R package. To isolate sexual differences, phenotypic sex was treated as the primary covariate. Population origin was strictly embedded as a confounding adjustment variable to account for ancestry-driven batch effects. Statistical significance was controlled using False Discovery Rate (FDR) threshold of \(q-value < 0.05\).
Setup and Sample Phenotypes
Sample Population Metrics
The sample group balances phenotypic sex and regional cohorts across 12 distinct repository entries. The baseline experimental structure is detailed below:
YRI Cohort: Comprises 3 male samples (ERR188044_chrX, ERR188104_chrX, ERR188454_chrX) and 3 female samples (ERR188234_chrX, ERR188273_chrX, ERR204916_chrX).
GBR Cohort: Comprises 3 male samples (ERR188257_chrX, ERR188383_chrX, ERR188401_chrX) and 3 female samples (ERR188245_chrX, ERR188337_chrX, ERR188428_chrX).
Exploratory Analysis
Results
Transcript Filtering
An initial set of 2,343 transcripts was extracted from the StringTie quantification step. To eliminate uninformative background noise and improve statistical power, transcripts with low variance across samples were pruned. Applying a filtration cutoff threshold of \(rowVar > 1\) successfully yielded 1,095 high-confidence transcripts retained for exploratory and differential expression processing.
Exploratory Variance Analysis
To understand global relationship structures within the filtered datasets, a Principal Component Analysis (PCA) was calculated on transcript-level Fragments Per Kilobase of transcript per Million mapped reads (FPKM) expression data.
As plotted in Figure 1, the first two principal components explained 27.1% of total variance (PC1: 14.4%, PC2: 12.7%). The distribution patterns reveal a modest separation based on biological sex along the axis trajectories. Concurrently, clear macro-clusters demonstrate underlying population structure, showing distinct spatial partitioning between European (GBR) and African (YRI) cohorts. This population grouping confirms the necessity of utilizing nested model adjustments within the F-test framework to avoid ancestry-driven false-positive discoveries.
Differential Expression
| geneNames | geneIDs | feature | id | fc | pval | qval | |
|---|---|---|---|---|---|---|---|
| 1058 | TSIX | MSTRG.331 | transcript | 1058 | 0.012 | 9.1e-09 | 5.0e-06 |
| 1059 | XIST | MSTRG.332 | transcript | 1059 | 0.002 | 6.9e-09 | 5.0e-06 |
| 435 | KDM6A | MSTRG.148 | transcript | 435 | 0.032 | 3.1e-05 | 1.1e-02 |
| feature | id | fc | pval | qval |
|---|---|---|---|---|
| gene | MSTRG.332 | 0.002 | 9.3e-10 | 5.3e-07 |
| gene | MSTRG.331 | 0.012 | 5.6e-09 | 1.6e-06 |
| gene | MSTRG.233 | 0.574 | 1.9e-05 | 3.6e-03 |
Statistical testing on the curated genomic features revealed a highly localized set of differentially expressed targets. As mapped out in Figure 2, only three specific genes crossed the designated horizontal significance threshold of \(q = 0.05\). Fold-change computations reflect expression levels of males relative to females; consequently, negative log2 fold-change parameters pinpoint strong female-biased gene expression patterns.
The three significant genes identified are:
XIST (MSTRG.332): Shows an extreme female bias with a fold change value of 0.00229 and a significance score (\(q = 5.3 \times 10^{-7}\)).
TSIX (MSTRG.331): Displays an aligned female bias with an intermediate fold change metric of 0.01181 (\(q = 1.6 \times 10^{-6}\)).
KDM6A (MSTRG.233): Reaches significant separation parameters with an adjusted fold change value of 0.57437 (\(q = 3.6 \times 10^{-3}\)).
Gene Abundance Quantification
To validate individual candidate patterns, expression profiles were plotted using log2 (FPKM + 1) metrics. The resulting boxplots (Figure 3) illustrate clear group distributions:
XIST and TSIX Expression: Both features exhibit definitive binary regulation profiles. Abundance levels are highly elevated in females (with median log2 values resting between 6.0 and 9.0) but drop down to zero baseline noise across all male samples. This is consistent with their known roles: XIST drives female-specific X-Chromosome Inactivation (XCI), while TSIX acts as its antisense regulator partner.
KDM6A Expression: Unlike the regulatory Ribonucleic acid (RNA), KDM6A is actively transcribed in both sexes. However, female samples present a statistically elevated expression ceiling compared to male profiles. This matches its classification as an XCI-escape gene that regularly maintains dual-dosage activity in female tissue.
Discussion and Conclusion
Biological Implications of Female-Biased Expression
The differential expression analysis of human Chromosome X transcripts revealed a highly localized regulatory signature. Only three genes - XIST, TSIX, and KDM6A - exhibited statistically significant expression differences between sexes (\(q < 0.05\)). All three candidates demonstrated explicit female-biased abundance. This tight localization underscores the stringent evolutionary conservation governing sex-chromosome dosage mechanisms in humans.
Mechanistic Synergy of XIST and TSIX
The identification of XIST (MSTRG.332) and TSIX (MSTRG.331) as the most statistically significant differentially expressed features aligns with established models of XCI (Lyon, 1961; Galupa and Heard, 2018). In female mammals, dosage compensation between XX and XY individuals is achieved by transcriptionally silencing one of the two female X chromosomes.
XIST Function: This long non-coding RNA (lncRNA) is transcribed exclusively from the future inactive X chromosome (\(X_i\)). It physically coats the chromosome in cis, recruiting repressive chromatin-modifying complexes to initiate heterochromatin silencing.
TSIX Function: Operating as an antisense lncRNA partner, TSIX is transcribed from the opposite strand (Lee and Lu, 1999) and overlaps the XIST locus. It acts as a negative regulator of XIST. Prior to inactivation, TSIX expression on the future active X chromosome (\(X_a\)) represses XIST accumulation, preserving transcription.
The binary expression profiles captured in the FPKM boxplots (Figure 3) — where both lncRNAs show near-zero baseline expression across all male samples — reflect this strict functional biology. Because males possess only a single, active X chromosome, the XIST/TSIX inactivation locus is never activated.
Dosage Escape by KDM6A
The significant female bias observed in KDM6A (MSTRG.233) highlights a distinct biological phenomenon: XCI escape. KDM6A encodes a histone demethylase responsible for removing repressive H3K27me3 marks, thereby promoting transcriptionally active chromatin states.
Unlike XIST and TSIX, KDM6A maintains active transcription in male individuals. However, its elevated expression in females confirms that it escapes complete epigenetic silencing (Balaton, Cotton and Brown, 2015) on the inactive X chromosome. Because KDM6A is transcribed from both the active and inactive X chromosomes in females, it avoids single-dosage constraint, resulting in a higher steady-state messenger RNA (mRNA) abundance relative to males. This dual-dosage profile may contribute to sex-specific differences in immune responses and oncogenic susceptibility, as KDM6A plays a key role in chromatin remodeling.
Conclusion
By controlling for confounding population structures via Ballgown’s nested F-test framework, this study isolated true sex-linked transcriptional signals from geographic background noise. The identification of XIST, TSIX, and KDM6A validates the RNAseq processing pipeline, as these targets represent the canonical core of human X-chromosome regulation. The clear separation of population cohorts in the exploratory PCA highlights the necessity of accounting for genetic ancestry in multi-population expression studies to prevent false-positive discoveries.
List of Acronyms
- DE
- Differential Expression
- FDR
- False Discovery Rate
- FPKM
- Fragments Per Kilobase of transcript per Million mapped reads
- GTF
- Gene Transfer Format
- PCA
- Principal Component Analysis
- QC
- Quality Control
- RNA
- Ribonucleic acid
- RNAseq
- RNA Sequencing
- TPM
- Transcripts Per Million
- XCI
- X-Chromosome Inactivation
- chrX
- Chromosome X
- lncRNA
- long non-coding RNA
- mRNA
- messenger RNA
Reference
Reuse
Citation
@online{allies2026,
author = {Allies, Devon},
title = {Differential {Expression} {Analysis} of {Chromosome} {X}
{RNA-seq} {Data}},
date = {2026-05-17},
langid = {en}
}